Celsion (CLSN -11.4%) sinks again today after noting in a SEC filing that it's entered into a...


Celsion (CLSN -11.4%) sinks again today after noting in a SEC filing that it's entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald to sell $25M worth of shares, from time to time. The stock cratered last week on news that its liver cancer drug TheromDox had failed its latest clinical trials.
Comments (2)
  • Nahodny Okoloiduci
    , contributor
    Comments (161) | Send Message
     
    OK current pps is $1.15 so it means dilution by 21M newly issued shares. That's quite a 2/3 of shares outstanding as of today. Just wow.
    4 Feb 2013, 12:51 PM Reply Like
  • hdavidfrancis
    , contributor
    Comment (1) | Send Message
     
    Are these guys at Celsion wearing masks? They should be held up for fraud as a small shareholder, they are wearing my patience and my wallet shin- H. David Francis, Pharm D
    5 Feb 2013, 06:10 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs